Read more > buff.ly/W9TAZ3b
Posts by TOGA
The 2025 Annual Report is here.
A strong year for TOGA’s Scientific Program.
Our Working Groups continued to drive innovation, reviewing 21 research concepts, with 19 receiving endorsement, reflecting the strength and quality of ideas across our membership.
Friday, 24 April 2026
Submit your abstract > buff.ly/vF8rEcT
Calling all researchers in the TOGA Community!
Abstract submissions for the 2026 TOGA ASM are closing soon.
If you’re part of the TOGA community, don’t miss the chance to contribute to this year’s exciting program of presentations and discussions.
Submission Deadline:
Registrations are open for the TOGA 2026 ASM!
Take advantage of discounted rates - early bird closed May 31 2026.
📅 Dates: July 15-17
📍 Location: Pullman Melbourne Albert Park
Register now > buff.ly/mF5L2BS
for lung cancer care in Australia and New Zealand.
Register for the ASM > buff.ly/kCPrHtz
Dropping tomorrow 🎧
Go behind the scenes of the 2026 TOGA ASM with A/Prof Surein Arulananda and members of the Local Organising Committee.
From standout sessions to emerging themes in thoracic oncology, this episode gives you a first look at what’s ahead, and why it matters
to date with the latest thinking and practical insights.
Listen on Apple: buff.ly/moIyAeu
Spotify: buff.ly/SX4y9MU
Show Notes: buff.ly/YEoyFeE
This episode is sponsored by Pfizer.
In this latest episode of Conversations in Lung Cancer Research, hear from leading experts as they unpack the complexities of ALK TKI sequencing, resistance patterns, and real-world decision-making in clinical practice.
This is a must-listen for clinicians looking to stay up
hearing from Dr Lavinia Tan who is presenting on 'Molecular Testing at Progression'.
📅 Date: April 28
⏰ Time: 6:30PM - 8:00PM
📍 Location: Online
Register now > buff.ly/wyywd4S
Join us for a practical and clinically focused webinar on lung cancer molecular reporting.
Our Beyond the NGS Report: Practical Interpretation for Lung Cancer Care webinar will provide practical guidance to support real-world decision-making.
We're looking forward to
on 'How to Read a Lung Cancer Molecular Report'.
📅 Date: April 28
⏰ Time: 6:30PM - 8:00PM
📍 Location: Online
Register now > buff.ly/wyywd4S
Strengthen your confidence in making sense of lung cancer molecular pathology reports in routine clinical settings, including when specialist molecular tumour board support is not readily available.
We can't wait to hear from A/Prof Caroline Cooper and Dr Jennifer Borowsky
distinguishing clinically relevant findings from non-actionable variants.
📅 Date: April 28
⏰ Time: 6:30PM - 8:00PM
📍 Location: Online
Register now > buff.ly/9XwDcp9
Thank-you Eisai for sponsoring the Beyond the NGS Report: Practical Interpretation for Lung Cancer Care webinar.
The session will provide medical oncologists with practical guidance on interpreting lung cancer molecular reports, identifying targetable alterations, and
We're back with an episode on ALK TKI sequencing in the Australian landscape.
Join Prof Ben Solomon, A/Prof Tim Clay and A/Prof Malinda Itchins as they discuss treatment for this subset of NSCLC and the advances through four generations of inhibitors.
Listen on Apple: buff.ly/L8TrfTn
This episode is sponsored by Pfizer.
🎧️ NEW EPISODE TOMORROW
Our host A/Prof Tim Clay sits down with Australian oncology luminaries Prof Ben Solomon and A/Prof Malinda Itchins to discuss the rapidly evolving landscape of Anaplastic Lymphoma Kinase (ALK) positive lung cancer.
Tune in from Friday, April 10th, at 8am.
molecular pathology reports in real-world clinical practice.
Hear from A/Prof Malinda Itchins on 'Translating Results into Treatment Decisions'.
📅 Date: April 28
⏰ Time: 6:30PM - 8:00PM
📍 Location: Online
Register now > buff.ly/wyywd4S
Build confidence in interpreting lung cancer molecular reports in this focused and practical webinar.
TOGA's Beyond the NGS Report: Practical Interpretation for Lung Cancer Care webinar brings together expert perspectives to help clinicians better understand lung cancer
patient-centred support to ongoing improvements in how we deliver treatment and ensuring access to the best therapeutics available.
Read more > buff.ly/tgSxSft
The Preventative and Quality Care Working Group represents TOGA’s commitment to improving the outcomes of thoracic cancers. This new working group ensures TOGA has representation and efforts across every front from earlier diagnosis, fair access to high-quality care,
The 2025 Annual Report is here.
Our TOGA community continues to grow. The 2025 Annual Report highlights a year of growth, engagement, and connection.
Learn more > buff.ly/jycFCn7
recognising actionable alterations, and differentiating clinically meaningful variants from those that are not actionable.
📅 Date: April 28
⏰ Time: 6:30PM - 8:00PM
📍 Location: Online
Register now > buff.ly/9XwDcp9
We’re delighted to welcome Johnson & Johnson as a sponsor of the Beyond the NGS Report: Practical Interpretation for Lung Cancer Care webinar.
This interactive session is designed to support medical oncologists in confidently interpreting lung cancer molecular reports,
clinical practice.
We're excited to hear from Prof Stephen Fox on 'Molecular Testing at Diagnosis'.
📅 Date: April 28
⏰ Time: 6:30PM - 8:00PM
📍 Location: Online
Register now > buff.ly/wyywd4S
Don’t miss this opportunity to deepen your understanding of lung cancer molecular reporting.
Join us for Beyond the NGS Report: Practical Interpretation for Lung Cancer Care, a webinar designed to help you confidently interpret lung cancer molecular pathology reports in
possible.
Explore the Annual Report > buff.ly/W9TAZ3b
The 2025 Annual Report is here.
Education remains at the heart of what we do.
For the first time in TOGA's history the ASM was held in Brisbane, bringing together 416 attendees.
Thank you to all our speakers, contributors, and attendees who made the education program